JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Prostate Apoptosis Response-4 (Par-4) as a Cancer Therapeutic Target
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Journal of Life Science
  • Volume 25, Issue 8,  2015, pp.947-952
  • Publisher : Korean Society of Life Science
  • DOI : 10.5352/JLS.2015.25.8.947
 Title & Authors
Prostate Apoptosis Response-4 (Par-4) as a Cancer Therapeutic Target
Woo, Seon Min; Kwon, Taeg Kyu;
  PDF(new window)
 Abstract
Prostate apoptosis response-4 (Par-4) was originally identified in androgen-independent prostate cancer cells undergoing apoptosis. Par-4 is ubiquitously expressed in normal cells and tissues, but it is downregulated in several types of cancers. Par-4 is a 38 kDa tumor suppressor protein encoded by the PARW gene. Par-4 promotes apoptosis in a variety of cancerous cells, but not in normal cells. In this review, we focused on the structure, expression and function of Par-4 in apoptotic signaling pathway. Functional domains of Par-4 include two nuclear localization sequences (NLS), a leucine zipper (LZ) domain, a nuclear export sequence (NES) and selective for apoptosis in cancer cell (SAC) domain. Many studies have underlined the importance of Par-4 in preventing cancer development. The activity of Par-4 is differently regulated by localization of intracellular and extracellular Par-4. Intracellular Par-4 inhibits Akt- and NF-κB-mediated cell survival pathways and downregulates Bcl-2 expression. Extracellular Par-4 activates the extrinsic apoptotic pathway by binding to cell surface receptor GRP78, a stress response protein that is in the endoplasmic reticulum (ER). Endogenous Par-4 sensitizes cancer cells to various apoptotic stimuli, while exogenous Par-4 enhances SAC domain-dependent apoptosis in cancer cells, but not normal cells. Therefore, Par-4 is an attractive target for cancer therapy.
 Keywords
Apoptosis;cancer;prostate apoptosis response-4 (Par-4);nuclear factor-κB (NF-κB);selective for apoptosis in cancer cell (SAC) domain;
 Language
Korean
 Cited by
 References
1.
Ahmed, M. M., Sheldon, D., Fruitwala, M. A., Venkatasubbarao, K., Lee, E. Y., Gupta, S., Wood, C., Mohiuddin, M. and Strodel, W. E. 2008. Downregulation of PAR-4, a pro-apoptotic gene, in pancreatic tumors harboring K-ras mutation. Int. J. Cancer 122, 63-70. crossref(new window)

2.
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N. and Perucho, M. 1988. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554. crossref(new window)

3.
Azmi, A. S., Ahmad, A., Banerjee, S., Rangnekar, V. M., Mohammad, R. M. and Sarkar, F. H. 2008. Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3′ diindolylmethane (DIM). Pharm. Res. 25, 2117-2124. crossref(new window)

4.
Barkett, M. and Gilmore, T. D. 1999. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18, 6910-6924. crossref(new window)

5.
Barradas, M., Monjas, A., Diaz-Meco, M. T., Serrano, M. and Moscat, J. 1999. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J. 18, 6362-6369. crossref(new window)

6.
Boehrer, S., Chow, K. U., Puccetti, E., Ruthardt, M., Godzisard, S., Krapohl, A., Schneider, B., Hoelzer, D., Mitrou, P. S., Rangnekar, V. M. and Weidmann, E. 2001. Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. Hematol. J. 2, 103-107. crossref(new window)

7.
Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.

8.
Burikhanov, R., Zhao, Y., Goswami, A., Qiu, S., Schwarze, S. R. and Rangnekar, V. M. 2009. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell 138, 377-388. crossref(new window)

9.
Chakraborty, M., Qiu, S. G., Vasudevan, K. M. and Rangnekar, V. M. 2001. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res. 61, 7255-7263.

10.
Chaudhry, P., Singh, M., Parent, S. and Asselin, E. 2012. Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation. Mol. Cell. Biol. 32, 826-839. crossref(new window)

11.
Cheema, S. K., Mishra, S. K., Rangnekar, V. M., Tari, A. M., Kumar, R. and Lopez-Berestein, G. 2003. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J. Biol. Chem. 278, 19995-20005. crossref(new window)

12.
Cook, J., Krishnan, S., Ananth, S., Sells, S. F., Shi, Y., Walther, M. M., Linehan, W. M., Sukhatme, V. P., Weinstein, M. H. and Rangnekar, V. M. 1999. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma. Oncogene 18, 1205-1208. crossref(new window)

13.
de Thonel, A., Hazoume, A., Kochin, V., Isoniemi, K., Jego, G., Fourmaux, E., Hammann, A., Mjahed, H., Filhol, O., Micheau, O., Rocchi, P., Mezger, V., Eriksson, J. E., Rangnekar, V. M. and Garrido, C. 2014. Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells. Cell Death Dis. 5, e1016. crossref(new window)

14.
Diaz-Meco, M. T., Lallena, M. J., Monjas, A., Frutos, S. and Moscat, J. 1999. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J. Biol .Chem. 274, 19606-19612. crossref(new window)

15.
Diaz-Meco, M. T. and Moscat, J. 2008. Akt regulation and lung cancer: a novel role and mechanism of action for the tumor suppressor Par-4. Cell Cycle 7, 2817-2820. crossref(new window)

16.
Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L. and Moscat, J. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86, 777-786. crossref(new window)

17.
Donninger, H., Hesson, L., Vos, M., Beebe, K., Gordon, L., Sidransky, D., Liu, J. W., Schlegel, T., Payne, S., Hartmann, A., Latif, F. and Clark, G. J. 2010. The Ras effector RASSF2 controls the PAR-4 tumor suppressor. Mol. Cell. Biol. 30, 2608-2620. crossref(new window)

18.
Downward, J. 2004. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 15, 177-182. crossref(new window)

19.
El-Guendy, N. and Rangnekar, V. M. 2003. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp. Cell Res. 283, 51-66. crossref(new window)

20.
El-Guendy, N., Zhao, Y., Gurumurthy, S., Burikhanov, R. and Rangnekar, V. M. 2003. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol. Cell. Biol. 23, 5516-5525. crossref(new window)

21.
Goswami, A., Burikhanov, R., de Thonel, A., Fujita, N., Goswami, M., Zhao, Y., Eriksson, J. E., Tsuruo, T. and Rangnekar, V. M. 2005. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol. Cell 20, 33-44. crossref(new window)

22.
Gurumurthy, S., Goswami, A., Vasudevan, K. M. and Rangnekar, V. M. 2005. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis. Mol. Cell. Biol. 25, 1146-1161. crossref(new window)

23.
Jagtap, J. C., Dawood, P., Shah, R. D., Chandrika, G., Natesh, K., Shiras, A., Hegde, A. S., Ranade, D. and Shastry, P. 2014. Expression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-inducedapoptosis. PLoS One. 9, e88505. crossref(new window)

24.
Jagtap, J. C., Parveen, D., Shah, R. D., Desai, A., Bhosale, D., Chugh, A., Ranade, D., Karnik, S., Khedkar, B., Mathur, A., Natesh, K., Chandrika, G. and Shastry, P. 2015. Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-inducedcell death. FEBS Open Bio. 5, 8-19. crossref(new window)

25.
Johnstone, R. W., See, R. H., Sells, S. F., Wang, J., Muthukkumar, S., Englert, C., Haber, D. A., Licht, J. D., Sugrue, S. P., Roberts, T., Rangnekar, V. M. and Shi, Y. 1996. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms’ tumor suppressor WT1. Mol. Cell. Biol. 16, 6945-6956. crossref(new window)

26.
Johnstone, R. W., Tommerup, N., Hansen, C., Vissing, H. and Shi, Y. 1998. Mapping of the human PAWR (par-4) gene to chromosome 12q21. Genomics 53, 241-243. crossref(new window)

27.
Kimura, M., Furukawa, T., Abe, T., Yatsuoka, T., Youssef, E. M., Yokoyama, T., Ouyang, H., Ohnishi, Y., Sunamura, M., Kobari, M., Matsuno, S. and Horii, A. 1998. Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. Cancer Res. 58, 2456-2460.

28.
Kline, C. L. and Irby, R. B. 2011. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU. Apoptosis 16, 1285-1294. crossref(new window)

29.
Kogel, D., Plottner, O., Landsberg, G., Christian, S. and Scheidtmann, K. H. 1998. Cloning and characterization of Dlk, a novel serine/threonine kinase that is tightly associated with chromatin and phosphorylates core histones. Oncogene 17, 2645-2654. crossref(new window)

30.
Kogel, D., Reimertz, C., Mech, P., Poppe, M., Fruhwald, M. C., Engemann, H., Scheidtmann, K. H. and Prehn, J. H. 2001. Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway. Br. J. Cancer 85, 1801-1808. crossref(new window)

31.
Lee, A. S. 2009. The Par-4-GRP78 TRAIL, more twists and turns. Cancer Biol. Ther. 8, 2103-2105.

32.
Lee, T. J., Jang, J. H., Noh, H. J., Park, E. J., Choi, K. S. and Kwon, T. K. 2010. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells. J. Cell. Biochem. 109, 885-895.

33.
Lee, T. J., Lee, J. T., Kim, S. H., Choi, Y. H., Song, K. S., Park, J. W. and Kwon, T. K. 2008. Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells. J. Cell. Biochem. 103, 358-368. crossref(new window)

34.
Moreno-Bueno, G., Fernandez-Marcos, P. J., Collado, M., Tendero, M. J., Rodriguez-Pinilla, S. M., Garcia-Cao, I., Hardisson, D., Diaz-Meco, M. T., Moscat, J., Serrano, M. and Palacios, J. 2007. Inactivation of the candidate tumor suppressorpar-4 in endometrial cancer. Cancer Res. 67, 1927-1934. crossref(new window)

35.
Nalca, A., Qiu, S. G., El-Guendy, N., Krishnan, S. and Rangnekar, V. M. 1999. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J. Biol. Chem. 274, 29976-29983. crossref(new window)

36.
Notaro, A., Sabella, S., Pellerito, O., Di Fiore, R., De Blasio, A., Vento, R., Calvaruso, G. and Giuliano, M. 2014. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis. Int. J. Biol. Sci. 10, 466-478. crossref(new window)

37.
Pereira, M. C., de Bessa-Garcia, S. A., Burikhanov, R., Pavanelli, A. C., Antunes, L., Rangnekar, V. M. and Nagai, M. A. 2013. Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells. Int. J. Oncol. 43, 531-538.

38.
Pruitt, K., Ulku, A. S., Frantz, K., Rojas, R. J., Muniz-Medina, V. M., Rangnekar, V. M., Der, C. J. and Shields, J. M. 2005. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J. Biol. Chem. 280, 23363-23370. crossref(new window)

39.
Qiu, G., Ahmed, M., Sells, S. F., Mohiuddin, M., Weinstein, M. H. and Rangnekar, V. M. 1999. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4. Oncogene 18, 623-631. crossref(new window)

40.
Rah, B., Amin, H., Yousuf, K., Khan, S., Jamwal, G., Mukherjee, D. and Goswami, A. 2012. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PLoS One. 7, e44039. crossref(new window)

41.
Rayet, B. and Gelinas, C. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18, 6938-6947. crossref(new window)

42.
Schneider, B. G., Rha, S. Y., Chung, H. C., Bravo, J. C., Mera, R., Torres, J. C., Plaisance, K. T. Jr., Schlegel, R., McBride, C. M., Reveles, X. T. and Leach, R. J. 2003. Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer. Mol. Pathol. 56, 141-149. crossref(new window)

43.
Schwarze, S. and Rangnekar, V. M. 2010. Targeting plasma membrane GRP78 for cancer growth inhibition. Cancer Biol. Ther. 9, 153-155. crossref(new window)

44.
Sells, S. F., Wood, D. P. Jr., Joshi-Barve, S. S., Muthukumar, S., Jacob, R. J., Crist, S. A., Humphreys, S. and Rangnekar, V. M. 1994. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 5, 457-466.

45.
Srinivasan, S., Ranga, R. S., Burikhanov, R., Han, S. S. and Chendil, D. 2007. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 67, 246-253. crossref(new window)

46.
Szegezdi, E., Logue, S. E., Gorman, A. M. and Samali, A. 2006. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 7, 880-885. crossref(new window)

47.
Thayyullathil, F., Pallichankandy, S., Rahman, A., Kizhakkayil, J., Chathoth, S., Patel, M. and Galadari, S. 2013. Caspase-3 mediated release of SAC domain containing fragment from Par-4 is necessary for the sphingosine-induced apoptosis in Jurkat cells. J. Mol. Signal. 8, 2. crossref(new window)

48.
Thayyullathil, F., Rahman, A., Pallichankandy, S., Patel, M. and Galadari, S. 2014. ROS-dependent prostate apoptosis response-4 (Par-4) up-regulation and ceramide generation are the prime signaling events associated with curcumin-induced autophagic cell death in human malignant glioma. FEBS Open Bio. 4, 763-776. crossref(new window)

49.
Zapata-Benavides, P., Mendez-Vazquez, J. L., GonzalezRocha, T. R., Zamora-Avila, D. E., Franco-Molina, M. A., Garza-Garza, R. and Rodriguez-Padilla, C. 2009. Expression of prostate apoptosis response (Par-4) is associated with progesterone receptor in breast cancer. Arch. Med. Res. 40, 595-599. crossref(new window)

50.
Zhao, Y., Burikhanov, R., Qiu, S., Lele, S. M., Jennings, C. D., Bondada, S., Spear, B. and Rangnekar, V. M. 2007. Cancer resistance in transgenic mice expressing the SAC module of Par-4. Cancer Res. 67, 9276-9285. crossref(new window)

51.
Zhao, Y. and Rangnekar, V. M. 2008. Apoptosis and tumor resistance conferred by Par-4. Cancer Biol. Ther. 7, 1867-1874. crossref(new window)